“Vaccination is the most important thing to strengthen the country’s fight against coronavirus. It released today the first commercial batch of #COVAXIN from Bharat Biotech’s plant in Ankleshwar, Gujarat. This will increase the supply of vaccines in the country and help the vaccine will reach all countries in India, ”Mandaviya tweeted shortly after the event.
Vaccination is the most important thing to strengthen the country in the fight against the Crown. Today in Ankleshwar, Gujarat, based at @BharatBiotech … https://t.co/xzgc0egwTQ
– Mansukh Mandaviya (@mansukhmandviya) 1630213474000
Earlier this month, the government had approved Bharat Biotech’s Ankleshwar-based manufacturing plant to produce the Covid-19 Covaxin vaccine.
In May, Bharat Biotech announced that it planned to produce an additional 200 million doses of Covaxin at its subsidiary facilities in Ankleshwar. The Hyderabad-based firm had stated that it would use the manufacturing plant of its wholly-owned unit, Chiron Behring, to add 200 million doses of Covaxin.
India administered 63.09 million doses of vaccine against Covid-19 on a national route until Sunday morning, according to data released by the Union Ministry of Health.